Company Info
Phone(650) 410-3200
Year Established
2016
Contacts
John KollinsPresident & CEO
Shunji Haruta, Ph.D.
COO
Mic Iwashima
VP & Head of Operations
Shannon Strom, PhD, R.A.C.
VP & Head of Regulatory Affairs
Company Description
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing STS101 (dihydroergotamine (DHE) nasal powder), a novel investigational therapeutic product candidate for the acute treatment of migraine.
